Most men start an ED treatment — a PDE5 inhibitor, a subscription, an injection protocol — and continue it indefinitely without reassessment. This is understandable (it's working, why change?) but suboptimal. Annual review can identify opportunities to reduce medication, change approach, or address new factors.
Why Reassess
Your body, health conditions, medications, and relationship context change over time. A treatment that was ideal 2 years ago may now be too much, too little, or the wrong approach entirely.
Common scenarios that annual review catches:
- Weight loss improving baseline function. A man who started tadalafil at BMI 35 and now weighs 25 may find he no longer needs medication — or needs a lower dose.
- New medications creating interactions. Starting a blood pressure medication, an SSRI, or an alpha-blocker changes the ED treatment equation.
- Condition progression requiring escalation. Worsening diabetes or cardiovascular disease may reduce PDE5 inhibitor effectiveness, warranting a switch to combination therapy or alternative approaches.
- Over-treatment. Some men continue daily tadalafil after the circumstances that warranted it have changed (e.g., performance anxiety resolved, new relationship established).
- Cost optimization. Newer generic options, different platforms, or insurance changes may make the same treatment significantly cheaper.
The Annual Checklist
Is the current treatment still working as well as when you started? If effectiveness has decreased, investigate why rather than just increasing the dose.
Has your health changed? New diagnoses, new medications, significant weight change, or mental health changes all affect ED and its treatment.
Is the current approach the most cost-effective? Generic availability expands regularly. A compounded formulation you started paying $20/dose for might now be achievable at $5/dose through a different source.
Are side effects bothering you? Side effects you tolerated initially may become less acceptable over time. Switching medications within the PDE5 class can resolve specific side effects (e.g., switching from sildenafil to tadalafil to reduce headache frequency).
Has your sexual frequency or relationship context changed? Daily tadalafil for a man having sex 3 times per week makes sense. Daily tadalafil for a man now having sex twice per month is potentially over-treating — on-demand dosing may be more appropriate and cheaper.
Are the underlying causes being addressed? ED medication treats the symptom. If the underlying cause is modifiable (weight, sleep apnea, depression, smoking), is anything being done about it? Annual review is a chance to refocus on root causes.
When to Step Down
Some men can reduce or discontinue ED medication after addressing underlying causes. Weight loss, CPAP therapy for sleep apnea, switching off ED-causing medications, testosterone replacement, or resolution of performance anxiety can all improve baseline erectile function enough to reduce pharmacological support.
A reasonable step-down approach: reduce the dose (100mg → 50mg), try as-needed instead of daily, or attempt sexual activity without medication to assess current baseline function. If the result is unsatisfactory, resume treatment — there's no penalty for checking.